Commodore Capital LP Q3 2021 Filing
Filed November 15, 2021
Portfolio Value
$379.3B
Holdings
29
Report Date
Q3 2021
Filing Type
13F-HR
All Holdings (29 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | OPHTEURIVERIC BIO INC | 2,750,137 | $44.7B | 11.78% | |
| 2 | ACRSACLARIS THERAPEUTICS INC | 2,190,291 | $39.4B | 10.39% | |
| 3 | CYTKCYTOKINETICS INC | 796,578 | $28.5B | 7.51% | |
| 4 | —DICERNA PHARMACEUTICALS INC | 1,292,251 | $26.1B | 6.87% | |
| 5 | CCCCC4 THERAPEUTICS INC | 481,094 | $21.5B | 5.67% | |
| 6 | KURAKURA ONCOLOGY INC | 999,433 | $18.7B | 4.94% | |
| 7 | CELCCELCUITY INC | 920,464 | $16.6B | 4.37% | |
| 8 | COGTCOGENT BIOSCIENCES INC | 1,912,511 | $16.1B | 4.24% | |
| 9 | MRUSMERUS N V | 718,136 | $15.8B | 4.17% | |
| 10 | CBAYUSDCYMABAY THERAPEUTICS INC | 4,169,896 | $15.2B | 4.01% | |
| 11 | —SATSUMA PHARMACEUTICALS INC | 3,118,761 | $14.5B | 3.83% | |
| 12 | VTGNUSDVISTAGEN THERAPEUTICS INC | 5,123,509 | $14.0B | 3.70% | |
| 13 | TCE2CELLDEX THERAPEUTICS INC NEW | 248,207 | $13.4B | 3.53% | |
| 14 | VRDNVIRIDIAN THERAPEUTICS INC | 667,674 | $11.0B | 2.90% | |
| 15 | TNYATENAYA THERAPEUTICS INC | 513,930 | $10.6B | 2.80% | |
| 16 | IOVAIOVANCE BIOTHERAPEUTICS INC | 362,869 | $8.9B | 2.36% | |
| 17 | XENEXENON PHARMACEUTICALS INC | 579,432 | $8.9B | 2.33% | |
| 18 | PTGXPROTAGONIST THERAPEUTICS INC | 498,079 | $8.8B | 2.33% | |
| 19 | KRON1USDKRONOS BIO INC | 298,839 | $6.3B | 1.65% | |
| 20 | RVMDREVOLUTION MEDICINES INC | 226,228 | $6.2B | 1.64% | |
| 21 | GNCAQGENOCEA BIOSCIENCES INC | 3,079,756 | $5.9B | 1.56% | |
| 22 | KALVKALVISTA PHARMACEUTICALS INC | 312,553 | $5.5B | 1.44% | |
| 23 | DYNDYNE THERAPEUTICS INC | 305,125 | $5.0B | 1.31% | |
| 24 | MREOMEREO BIOPHARMA GROUP PLC | 1,972,958 | $4.8B | 1.26% | |
| 25 | PMVPPMV PHARMACEUTICALS INC | 125,000 | $3.7B | 0.98% | |
| 26 | IVAINVENTIVA SA | 262,658 | $3.7B | 0.98% | |
| 27 | —BCLS ACQUISITION CORP | 250,000 | $2.5B | 0.66% | |
| 28 | CATBUSDASTRIA THERAPEUTICS INC | 239,270 | $2.1B | 0.56% | |
| 29 | SPRYSILVERBACK THERAPEUTICS INC | 97,143 | $969.0M | 0.26% |